FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968534453> ?p ?o ?g. }

• W1968534453 endingPage "803" @default.
• W1968534453 startingPage "797" @default.
• W1968534453 abstract "Background/Aims TNF-α is involved in the development of bacterial translocation in rats with cirrhosis. The aim of the current study was to evaluate the effect of anti-TNF-α mAb treatment on the incidence of bacterial translocation and systemic infections in rats with cirrhosis and ascites. Methods Thirty rats with cirrhosis and ascites were randomly assigned to receive two intraperitoneal doses of anti-TNF-α mAb, distilled water or immunoglobulin on days 0 and 4. On day 10, a laparotomy was performed. Results One out of 11 animals receiving anti-TNF-α mAb treatment, 7 out of 10 of the placebo group (p < 0.01), and 5 out of 9 of the IgG group developed bacterial translocation (p < 0.05). A significantly reduced number of systemic infections were observed in animals receiving anti TNF-α mAb treatment vs animals receiving placebo (p < 0.01). TNF-α in serum at laparotomy in animals receiving anti-TNF-α mAb was higher than that in the rest of groups and was also higher in the overall series of animals showing bacterial translocation. Conclusions In the experimental model of CCl4-induced rat with cirrhosis and ascitic fluid, anti-TNF-α mAb administration decreases the incidence of bacterial translocation, in a TNF-α/sTNF-α receptor-independent manner, without increasing the risk of systemic infections. TNF-α is involved in the development of bacterial translocation in rats with cirrhosis. The aim of the current study was to evaluate the effect of anti-TNF-α mAb treatment on the incidence of bacterial translocation and systemic infections in rats with cirrhosis and ascites. Thirty rats with cirrhosis and ascites were randomly assigned to receive two intraperitoneal doses of anti-TNF-α mAb, distilled water or immunoglobulin on days 0 and 4. On day 10, a laparotomy was performed. One out of 11 animals receiving anti-TNF-α mAb treatment, 7 out of 10 of the placebo group (p < 0.01), and 5 out of 9 of the IgG group developed bacterial translocation (p < 0.05). A significantly reduced number of systemic infections were observed in animals receiving anti TNF-α mAb treatment vs animals receiving placebo (p < 0.01). TNF-α in serum at laparotomy in animals receiving anti-TNF-α mAb was higher than that in the rest of groups and was also higher in the overall series of animals showing bacterial translocation. In the experimental model of CCl4-induced rat with cirrhosis and ascitic fluid, anti-TNF-α mAb administration decreases the incidence of bacterial translocation, in a TNF-α/sTNF-α receptor-independent manner, without increasing the risk of systemic infections." @default.
• W1968534453 created "2016-06-24" @default.
• W1968534453 creator A5001893683 @default.
• W1968534453 creator A5010721047 @default.
• W1968534453 creator A5018314837 @default.
• W1968534453 creator A5032816072 @default.
• W1968534453 creator A5034682808 @default.
• W1968534453 creator A5037040597 @default.
• W1968534453 creator A5041984607 @default.
• W1968534453 creator A5042243422 @default.
• W1968534453 creator A5049474524 @default.
• W1968534453 creator A5051374525 @default.
• W1968534453 creator A5052525506 @default.
• W1968534453 creator A5073300366 @default.
• W1968534453 creator A5088654937 @default.
• W1968534453 date "2007-05-01" @default.
• W1968534453 modified "2023-10-18" @default.
• W1968534453 title "Bacterial translocation is downregulated by anti-TNF-α monoclonal antibody administration in rats with cirrhosis and ascites" @default.
• W1968534453 cites W1533755741 @default.
• W1968534453 cites W1967467373 @default.
• W1968534453 cites W198706224 @default.
• W1968534453 cites W1989841036 @default.
• W1968534453 cites W1991615383 @default.
• W1968534453 cites W1994750434 @default.
• W1968534453 cites W2002271132 @default.
• W1968534453 cites W2005432852 @default.
• W1968534453 cites W2006367658 @default.
• W1968534453 cites W2028008812 @default.
• W1968534453 cites W2030603647 @default.
• W1968534453 cites W2034647223 @default.
• W1968534453 cites W2035597483 @default.
• W1968534453 cites W2051759557 @default.
• W1968534453 cites W2082894153 @default.
• W1968534453 cites W2083895259 @default.
• W1968534453 cites W2093473651 @default.
• W1968534453 cites W2117637609 @default.
• W1968534453 cites W2124743988 @default.
• W1968534453 cites W2144233065 @default.
• W1968534453 cites W2156015271 @default.
• W1968534453 cites W2157196642 @default.
• W1968534453 cites W2165252059 @default.
• W1968534453 cites W2182204751 @default.
• W1968534453 cites W265035167 @default.
• W1968534453 doi "https://doi.org/10.1016/j.jhep.2006.11.018" @default.
• W1968534453 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17321632" @default.
• W1968534453 hasPublicationYear "2007" @default.
• W1968534453 type Work @default.
• W1968534453 sameAs 1968534453 @default.
• W1968534453 citedByCount "49" @default.
• W1968534453 countsByYear W19685344532012 @default.
• W1968534453 countsByYear W19685344532013 @default.
• W1968534453 countsByYear W19685344532014 @default.
• W1968534453 countsByYear W19685344532015 @default.
• W1968534453 countsByYear W19685344532016 @default.
• W1968534453 countsByYear W19685344532017 @default.
• W1968534453 countsByYear W19685344532018 @default.
• W1968534453 countsByYear W19685344532019 @default.
• W1968534453 countsByYear W19685344532020 @default.
• W1968534453 countsByYear W19685344532021 @default.
• W1968534453 countsByYear W19685344532022 @default.
• W1968534453 countsByYear W19685344532023 @default.
• W1968534453 crossrefType "journal-article" @default.
• W1968534453 hasAuthorship W1968534453A5001893683 @default.
• W1968534453 hasAuthorship W1968534453A5010721047 @default.
• W1968534453 hasAuthorship W1968534453A5018314837 @default.
• W1968534453 hasAuthorship W1968534453A5032816072 @default.
• W1968534453 hasAuthorship W1968534453A5034682808 @default.
• W1968534453 hasAuthorship W1968534453A5037040597 @default.
• W1968534453 hasAuthorship W1968534453A5041984607 @default.
• W1968534453 hasAuthorship W1968534453A5042243422 @default.
• W1968534453 hasAuthorship W1968534453A5049474524 @default.
• W1968534453 hasAuthorship W1968534453A5051374525 @default.
• W1968534453 hasAuthorship W1968534453A5052525506 @default.
• W1968534453 hasAuthorship W1968534453A5073300366 @default.
• W1968534453 hasAuthorship W1968534453A5088654937 @default.
• W1968534453 hasConcept C104317684 @default.
• W1968534453 hasConcept C126322002 @default.
• W1968534453 hasConcept C138626823 @default.
• W1968534453 hasConcept C142724271 @default.
• W1968534453 hasConcept C159654299 @default.
• W1968534453 hasConcept C17991360 @default.
• W1968534453 hasConcept C203014093 @default.
• W1968534453 hasConcept C204787440 @default.
• W1968534453 hasConcept C27081682 @default.
• W1968534453 hasConcept C2777214474 @default.
• W1968534453 hasConcept C2777364826 @default.
• W1968534453 hasConcept C2780496750 @default.
• W1968534453 hasConcept C542903549 @default.
• W1968534453 hasConcept C55493867 @default.
• W1968534453 hasConcept C71924100 @default.
• W1968534453 hasConcept C86803240 @default.
• W1968534453 hasConcept C90924648 @default.
• W1968534453 hasConceptScore W1968534453C104317684 @default.
• W1968534453 hasConceptScore W1968534453C126322002 @default.
• W1968534453 hasConceptScore W1968534453C138626823 @default.
• W1968534453 hasConceptScore W1968534453C142724271 @default.
• W1968534453 hasConceptScore W1968534453C159654299 @default.
• W1968534453 hasConceptScore W1968534453C17991360 @default.

• next